Budget Amount *help |
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2014: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2013: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2012: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Outline of Final Research Achievements |
In this study, we tried to develop early diagnostic markers for aging-related peripheral neuropathy and novel anti-aging therapies. Our results suggest that urinary liver-type fatty acid binding protein, quantitative sensory testing(QST), serum or urinary Glycer-glyceraldehyde-derived advanced glycation end product (Glycer-AGEs), small-fiber pain threshold values, and amount of the deposition of alpha-synuclein in peripheral nerves are the most useful methods to diagnose the aging-related peripheral neuropathy. Our present finding may have some implications for developing novel anti-aging therapies.
|